Finally, in pathology, some patients with autism spectrum disorder, schizophrenia and epilepsy contain mutations in GPHN gene that encodes the G-domain of gephyrin.12 It remains to be determined to what extent these mutations and deletions of gephyrin alter its phase separation properties and potentially modulate the molecular basis of these complex diseases. The gene discussed is GPHN; the disease is epilepsy.